The art and science of running a successful pharmaceutical company.
May 14, 2013
By:
Pete Mehr, PhD, Merkle
This paper focuses on how customer centricity can unlock significant financial gains for pharmaceutical companies. It briefly reviews the historical promotion model, the factors in the industry that are driving the change, and then goes into depth on what it means to be customer centric and how to implement a customer-centric model.
|
|
May 1, 2013
By:
William Looney
What is industry icon Fred Hassan's management formula for staying fresh in an era of market churn?
|
May 1, 2013
In the world of patient education, processes, policies, and oversight differ vastly. There is no overarching governance structure. There isn't an accreditation process for educational interventions or patient advocacy organizations that develop the education.
|
May 1, 2013
By:
Mary Jo Lamberti, Ken Getz
New research from the Tufts Center for the Study of Drug Development identifies a significant contributor to the rising cost of clinical trials—the first step in meeting a growing strategic imperative to help senior management and the regulatory community craft new approaches to make trials more efficient in delivering results to clinicians and patients.
|
May 1, 2013
By:
Stan Bernard, MD
Pharma professionals need to find new competitive—not commercial—models to succeed in the competitive stage of the industry's lifecycle.
|
|
May 1, 2013
New approaches to managing reimbursements for pharmacy benefit programs are testing Big Pharma.
|
March 1, 2013
By:
Alyse Forcellina, Can Akannac
A proactive approach to talent and organization planning is the hidden trump card in prevailing with payers.
|
March 1, 2013
By:
Ken Getz
Ken Getz of the Tufts University Center for the Study of Drug Development (CSDD) explains how building a stakeholder outreach agenda around the community pharmacist can lead to a better outcome in managing the complex ins and outs of a trial protocol.
|
March 1, 2013
By:
Ben Bonifant, Scott Setrakian
Companies that adopt this new methodology will have a longstanding competitive advantage over those companies conducting business as usual.
|
|
PharmExec Blog
Follow Us
RSS
Bookstore
